Advanced searches left 3/3

Cancer Immunotherapy - PubAg

Summarized by Plex Scholar
Last Updated: 16 October 2021

* If you want to update the article please login/register

Inflammatory Markers in Cancer Immunotherapy

Persistent swelling is taken into consideration a major risk aspect for cancer formation. Cancer associated inflammation is known to take place in the tumor microenvironment and in the systemic flow, and is correlated with disease development and prognosis in many cancers cells. Cancer has found methods to escape the immune response; a path that can undermine the natural immune response is using obstructing immune checkpoints.

Source link: https://pubag.nal.usda.gov/catalog/7350887


Improving safety of cancer immunotherapy via delivery technology

Advancements in molecular mechanisms underlying immune-suppressive tumor microenvironment and standard shifts in the cancer-immunity response cycle have greatly altered the landscape of cancer immunotherapy. In this Review, we first introduce immune-related adverse effects of major immunotherapies and the underlying mechanisms, summarize techniques of designingde bioengineering and shipment systems to reduce their immunotoxicities, and highlight the importance of the advancement of immunotoxicity-related pet versions.

Source link: https://pubag.nal.usda.gov/catalog/7132942


Understanding and treating the inflammatory adverse events of cancer immunotherapy

Inflammatory poisonings are not just a major issue for Food and Drug Administration -accepted checkpoint blockade and chimeric antigen receptor T cell treatments, however restrict the development and use of combination treatments.

Source link: https://pubag.nal.usda.gov/catalog/7313761


Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives

Myeloid-derived suppressor cells are badly mature and heterogeneous cells of inherent immunity that their population is increased considerably in cancer patients. MDSCs represent 3 subsets including CD14 ⁺ monocytic, CD15 ⁺ granulocytic and Lin ⁻ early precursor cells. Assessment of MDSCs can provide beneficial details from cancer immunity state, and it can be an indication of growth diagnosis. After that, techniques are recommended to improve the power of immune system versus MDSCs.

Source link: https://pubag.nal.usda.gov/catalog/7376477


Metabolic interventions: A new insight into the cancer immunotherapy

Comparable to cancer cells, triggered T cells additionally perform international metabolic reprogramming for their proliferation and effect functions when recruited to the tumor microenvironment. Hence, healing methods might intend to restore T cell metabolic process and anti-tumor responses in the TME by targeting the metabolic dependancy of cancer cells. We additionally talk about potential therapeutic treatment strategies for targeting metabolic pathways to enhance cancer immunotherapy efficacy.

Source link: https://pubag.nal.usda.gov/catalog/7158914


Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy

Right here, we highlight the most recent breakthroughs in recognizing creatine regulation of T cell antitumor immunity, a topic that has previously gained little attention in the creatine study area. The possible application of creatine supplementation for cancer immunotherapy and the appropriate considerations are discussed.

Source link: https://pubag.nal.usda.gov/catalog/7388589


Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy

Cancer immunotherapy, leveraging the host's coordinated immune system to combat versus growth has been clinically validated. Nonetheless, the small response owing to the several ways of tumor immune evasion is just one of the challenges in cancer immunotherapy. Nanomaterials can give flexible strategies to recognize the premium spatiotemporal control over immunomodulation to enhance immune responses, ultimately enhancing the healing advantages and lowering poisoning. Below, the prospective medicines made use of in TAM-centered cancer treatment in clinic are summed up and the recent advancements of TAMs targeted nanomedicines in this filed are highlighted.

Source link: https://pubag.nal.usda.gov/catalog/7193763


Exosomes as mediators of immune regulation and immunotherapy in cancer

In cancer, depending on the context, exosomes can potentiate the advancement or oppose of an aggressive lump microenvironment, therefore affecting tumor progression and medical outcome. We additionally talk about the translational possibility of crafted exosomes as immunomodulatory agents for cancer therapy.

Source link: https://pubag.nal.usda.gov/catalog/7225624


Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy

Immunogenic cell death happening by chemical and physical stimulations has shown the possible to turn on a flexible immune response in the immune-competent living body through the launch of danger-associated molecular patterns into the tumor microenvironment. Nevertheless, limitations to the long-lasting immune responses and systemic poisoning of conventional ICD inducers have resulted in unsuitable healing effectiveness in ICD-based cancer immunotherapy. Ultimately, we go over the expected difficulties and future direction of nanoparticle-based ICD inducers to provide approaches for boosting ICD in cancer immunotherapy.

Source link: https://pubag.nal.usda.gov/catalog/7380767


Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy

The tumor microenvironment is composed mainly of growth cells, tumorinfiltrating immune cells, and matrix parts. Recent medical studies have shown that growth immune cell seepage is connected to the level of sensitivity of immunotherapy and the diagnosis of patients with bladder cancer. Our study showed that ICI ratings in immunotherapy might be a valid biomarker for the prognosis of patients and a predictive indicator. The analysis of ICI patterns of a bigger mate of examples would increase our cognition of TME, and the here and now study might assist the strategies of immunotherapy for patients with BC.

Source link: https://pubag.nal.usda.gov/catalog/7409628

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions